Animal model to pave way for age-related macular degeneration treatmentNovember 14th, 2007 - 1:58 am ICT by admin
In order to prevent the basal deposits from forming, researchers developed an animal model to understand the mechanisms that cause them to form in the first place.
“To better develop treatments for preventing the progression of AMD, we need to understand the real biochemical details of how AMD occurs,” said the lead author Eric A. Pierce, MD, PhD, and Associate Professor of Ophthalmology at Penn’s K.M Kirby Center for Molecular Ophthalmology.
“To do that, we need a model, and now we have one,” he added.
Some forms of macular degeneration are inherited, and one type is thought to be caused by a mutation in the Efemp1 gene.
Researchers created a mouse model of this inherited disorder by introducing the disease-causing mutation into the Efemp1 gene of mice. The resulting Efemp1-mutant mice develop the same basal deposits as people with AMD.
They plan to use the Efemp1-mutant mice to study how basal deposits form and what they are made of. The mice can also be used to test potential treatments to prevent basal deposit formation.
“By making this particular mutant mouse, we’ve made a model of early macular degeneration that’s caused by a mutation we know produces macular degeneration in people,” Pierce said.
“We think it’s going to be a good model to study the pathogenesis of basal deposits,” he added.
AMD is the leading cause of vision loss in elderly people, affecting more than 10 million people in the U.S. and about 50 million worldwide. Although it is a common and debilitating condition, prevention and treatment options are limited because AMD is considered a difficult condition to study.
This is because it develops late in life - patients typically show symptoms of AMD after 60, and the only samples researchers could use for study were from people who died while they had the early stages of AMD, and at that point, the tissue is not useful to study the condition’s progression.
Therefore, researchers have now developed a model, which they claim is the first important step in developing treatment for the disease.
The study is published in the October issue of Human Molecular Genetics. (ANI)
- Early AMD linked to smoking, cholesterol levels - Jun 15, 2010
- Indian origin scientist's gene therapy shows promise in slowing AMD - Apr 30, 2011
- How omega-3 fatty acids keep blindness at bay - Feb 10, 2011
- Grapes can stave off age-related blindness - Jan 15, 2012
- Eating oily fish keeps blindness at bay - Dec 02, 2010
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Additional genes linked to age-related macular degeneration identified - Apr 13, 2010
- Near infra-red light can heal damaged vision - Apr 20, 2011
- Age-related macular degeneration risk on the rise for Asians - May 02, 2010
- High Vitamin D levels 'may prevent age-related vision loss' - Apr 12, 2011
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Eating fish 'cuts women's eyesight loss risk in old age' - Mar 15, 2011
- Blinding disease drug shows promise for diabetic retinopathy patients - Apr 28, 2010
- Drugs to treat age-related blindness - Feb 07, 2011
- Pot-bellied men run risk of going blind - Apr 03, 2011
Tags: age related macular degeneration, amd, basement membrane, deposit formation, drusenmal model, gene researchers, inherited disorder, kirby center, macular degeneration treatment, molecular ophthalmology, mutant mice, mutant mouse, mutation, retinal pigment epithelium